KNSA Kiniksa Pharmaceuticals International, Plc

$55.22 +1.84%

Healthcare · Pharmaceutical Preparations

Kiniksa Pharmaceuticals International, Plc (KNSA) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $4.2 billion. Shares last traded at $55.22, 8.4% below their 52-week high. Over the past year the stock is up 97.5%. KNSA trades at a price-to-earnings ratio of 71.61, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 8.7%, above the peer median of -0.1%. Revenue grew 60.1% year over year.

Market Cap

$4.2B

Shares Out

76.5M

EPS (TTM)

$1.29

P/E Ratio

42.81

P/S Ratio

6.24

P/B Ratio

6.98

Dividend / Share

—

Dividend Yield

—

52-Week High

$60.29

52-Week Low

$26.27

Volume

46,811

Avg Vol (3m)

38,301.048

Performance

+7.18%

+3.49%

+21.12%

+33.45%

YTD

+31.49%

+97.50%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

63.60

SMA (50)

$51.11

SMA (200)

$43.98

Price vs SMA50

+8.03%

Price vs SMA200

+25.57%

ATR (14)

$2.16

Financials

Revenue

$678M

Net Income

$59M

Gross Margin

—

Operating Margin

11.4%

Net Margin

8.7%

Return on Equity

9.7%

Return on Assets

7.1%

Current Ratio

3.79

Debt / Equity

0.36

Revenue Growth (YoY)

+60.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.27	2026-04-28
FY 2025	$0.75	2026-02-24
Q3 2025	$0.57	2025-10-28
Q2 2025	$0.34	2025-07-29
Q1 2026	$0.11	2026-04-28
FY 2025	$-0.60	2026-02-24

Full earnings history →

Pharmaceutical Preparations peers

KNSA vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

71.61 / 16.82 med

+326% premium

P/S vs peers

6.24 / 3.54 med

+76% premium

Net margin vs peers

8.7% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.